# Novel Use Of Hydroxyurea in an African Region With Malaria

> **NCT01976416** · PHASE3 · COMPLETED · sponsor: **Indiana University** · enrollment: 208 (actual)

## Conditions studied

- Sickle Cell Anemia
- Sickle Cell Disease
- Malaria

## Interventions

- **DRUG:** Hydroxyurea
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01976416
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-10
- **Final completion:** 2017-11
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2018-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01976416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01976416, "Novel Use Of Hydroxyurea in an African Region With Malaria". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01976416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*